ArticleDiagnostics (Basel, Switzerland)2020
Melanoma Diagnosis Using Deep Learning and Fuzzy Logic.
Article in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Machine Learning Techniques, Applications, and Potential Future Opportunities in Pressure Injuries (Bedsores) Management: A Systematic Review.International journal of environmental research and public health · 2023Pooled it
- New Trends in Melanoma Detection Using Neural Networks: A Systematic Review.Sensors (Basel, Switzerland) · 2022Pooled it
- How good are artificial intelligence tools at identifying benign skin lesions? A systematic review and meta-analysis of the specificity of artificial intelligence tools in diagnosing suspicious skin lesions.Skin health and disease · 2026Review
- MSF-VMDNet for multi class segmentation of skin cancer whole slide images using a multi frequency dual encoder network.Scientific reports · 2026Article
- A Systematic Literature Review of You Only Look Once Architectures (v1-v12) in Healthcare Systems.Diagnostics (Basel, Switzerland) · 2026Review
- Skin tumor identification by means of convolutional neural network and improved gray wolf optimizer.Frontiers in oncology · 2026Article
- The Potential of Circulating miR-193b, miR-146b-3p and miR-483-3p as Noninvasive Biomarkers in Cutaneous Melanoma Patients.Molecular biotechnology · 2024Article
- Survival estimation of oral cancer using fuzzy deep learning.BMC oral health · 2024Article
- Article
- An efficient multi-class classification of skin cancer using optimized vision transformer.Medical & biological engineering & computing · 2024Article
- Article
- Optical Coherence Tomography as a Valuable Tool for the Evaluation of Cutaneous Kaposi Sarcoma Treated with Imiquimod 5% Cream.Diagnostics (Basel, Switzerland) · 2023Article
- Accuracy of a Smartphone-Based Artificial Intelligence Application for Classification of Melanomas, Melanocytic Nevi, and Seborrheic Keratoses.Diagnostics (Basel, Switzerland) · 2023Article
- Henry Gas Solubility Optimization Algorithm based Feature Extraction in Dermoscopic Images Analysis of Skin Cancer.Cancers · 2023Article
- MSCDNet-based multi-class classification of skin cancer using dermoscopy images.PeerJ. Computer science · 2023Article
- Skin Cancer Diagnosis Based on Neutrosophic Features with a Deep Neural Network.Sensors (Basel, Switzerland) · 2022Article
- Efficacy of a Deep Learning Convolutional Neural Network System for Melanoma Diagnosis in a Hospital Population.International journal of environmental research and public health · 2022Article
- MSeg-Net: A Melanoma Mole Segmentation Network Using CornerNet and FuzzyComputational and mathematical methods in medicine · 2022Article
- The role of AI technology in prediction, diagnosis and treatment of colorectal cancer.Artificial intelligence review · 2022Article
- Lung Nodules in Melanoma Patients: Morphologic Criteria to Differentiate Non-Metastatic and Metastatic Lesions.Diagnostics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanoma or malignant melanoma is a type of skin cancer that develops when melanocyte cells, damaged by excessive exposure to harmful UV radiations, start to grow out of control. Though less common than some other kinds of skin cancers, it is more dangerous because it rapidly metastasizes if not diagnosed and treated at an early stage. The distinction between benign and melanocytic lesions could at times be perplexing, but the manifestations of the disease could fairly be distinguished by a skilled study of its histopathological and clinical features. In recent years, deep convolutional neural networks (DCNNs) have succeeded in achieving more encouraging results yet faster and computationally effective systems for detection of the fatal disease are the need of the hour. This paper presents a deep learning-based 'You Only Look Once (YOLO)' algorithm, which is based on the application of DCNNs to detect melanoma from dermoscopic and digital images and offer faster and more precise output as compared to conventional CNNs. In terms with the location of the identified object in the cell, this network predicts the bounding box of the detected object and the class confidence score. The highlight of the paper, however, lies in its infusion of certain resourceful concepts like two phase segmentation done by a combination of the graph theory using minimal spanning tree concept and L-type fuzzy number based approximations and mathematical extraction of the actual affected area of the lesion region during feature extraction process. Experimented on a total of 20250 images from three publicly accessible datasets-PH2, International Symposium on Biomedical Imaging (ISBI) 2017 and The International Skin Imaging Collaboration (ISIC) 2019, encouraging results have been obtained. It achieved a Jac score of 79.84% on ISIC 2019 dataset and 86.99% and 88.64% on ISBI 2017 and PH2 datasets, respectively. Upon comparison of the pre-defined parameters with recent works in this area yielded comparatively superior output in most cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.